Transdermal Hormone Therapy stock supply shortage update – 11 October 2024 HT Patches Communication – Estradot 25, Evorel 100 and Evorel Conti OOS- October 2024
Evorel back in stock Adcock Ingram has advised that the stock issues around their Evorel range have improved, and the full range is back in stock including the Evorel
Due to ongoing manufacturing constraints, Adcock are experiencing erratic supply of Estalis and Estradot 50 μg menopause hormone therapy (MHT) patches. This is a global issue, impacting countries around the world. As
Adcock Ingram have advised that the stock issues around their Evorel range have been resolved and the full range is back in stock. For further information : Adcock Ingram Customer
Please find the latest (February 2021) Transdermal Hormone Therapy Patches Stock Supply Update HERE
25 February 20-21 Please see attached the latest statement from Bayer regarding Angeliq Stock Click HERE for more details
28 Oct 2020 Dear Colleagues Click HERE for more details. Kind regards Dr Trudy SmithGynaecology OncologistMBBCh ,FCOG, Cert Gynae OncPresident South African Menopause Society
